Q4 2020 Arcturus Therapeutics Holdings Inc Earnings Call Transcript
Greetings, and welcome to the Arcturus Therapeutics Fourth Quarter and Full Year 2020 Earnings Call. (Operator Instructions)
As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Neda Safarzadeh, Head of Investor Relations, Public Relations and Marketing. Thank you, Neda. You may begin.
/&
Thank you, operator, and good afternoon, everyone. We are joined today by Joseph Payne, President and CEO; Andy Sassine, CFO; Dr. Pad Chivukula, CSO and COO; Dr. Steve Hughes, our Chief Medical Officer; and Professor Eng Ooi, Deputy Director of Emerging Infectious Diseases program from Duke-NUS Medical School, who is also in Arcturus' Vaccine Platform Scientific Advisory Board.
Before we begin, I would like to remind everyone that except for statements of historical facts, the statements made by management and any responses to questions on this conference call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
